Explore the latest documents from the company, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.
2027
Earnings, Q1 FY2027
Validated titanium capacity meets advancing defense programs, backed by US$96.7m in available liquidity.
2026
Investor update
Validated capacity and GenX scale-up shift the focus to repeat customer orders.
Earnings, H2 FY2026
Annual
Titan Project's feasibility study shows strong economics and strategic value for U.S. critical minerals.
Investor update
Ramping up U.S. titanium production with innovative technology and strong government backing.
Earnings, Q4 FY2026
Expanded titanium production and secured $50M in new funding to accelerate growth.
Company presentation
Scaling up as a leading U.S. titanium and critical minerals supplier with strong government backing.
Investor update
Scaling new titanium technology, U.S. production ramps to meet surging defense and industrial demand.
Earnings, Q3 FY2026
Continuous titanium production ramped up, with strong cash and government support for expansion.
Earnings, H1 FY2026
Expanded U.S. titanium production, secured major government funding, and increased net loss on higher R&D.
Earnings, Q2 FY2026
Titanium manufacturing expansion accelerates with robust funding and new defense contracts.
Earnings, Q1 FY2026
Titanium production capacity up 60%, with major U.S.-backed expansion and strong cash position.
2025
Earnings, H2 FY2025
Annual
Commercial titanium production ramped up, major U.S. funding secured, net loss $35.3M in 2025.
Earnings, Q4 FY2025
Titanium production ramping up with robust funding and U.S. government backing.
Sidoti's Small-Cap Virtual Conference
Innovative titanium supply chain reshoring accelerates with strong funding and market expansion.
Earnings, Q3 FY2025
Commissioning and funding advances position IperionX for major titanium production growth.
Earnings, H1 FY2025
First commercial titanium production, major contracts, and U.S. DoD funding drive IperionX's growth.
Earnings, Q2 FY2025
First end-to-end titanium powder production and $66M raise position IperionX for 2025 growth.
Earnings, Q1 FY2025
First commercial-scale titanium production achieved, Ford contract secured, and strong cash position.
2024
Earnings, H2 FY2024
Annual
Net loss increased to $21.8 million as titanium commercialization advanced and funding needs remain.
Investor Presentation
Low-cost, sustainable titanium production is scaling in the U.S. with advanced proprietary technologies.
Earnings, Q4 FY2024
Virginia titanium production ramps up as IperionX secures funding and strategic partnerships.
Corporate Presentation
Scaling U.S. titanium production with innovative, low-cost, and sustainable technologies.